Over the past two months, much ink has been spilled regarding the exploits of Nobel laureates Abhijit Banerjee, Esther Duflo, and Michael Kremer and their pioneering work with randomised controlled trials (RCTs). Most have been positive, but in spite of the trio’s achievements, naysayers persist. For the uninitiated, an RCT…